Please provide your email address to receive an email when new articles are posted on . Interatrial shunt implant lowered HF hospitalization risk for patients with HFrEF vs. placebo. However, patients ...

FDA advisors on Wednesday will deliberate on whether shunt therapy still has a narrow path forward in heart failure after a disappointing pivotal trial. In its premarket approval application for the ...

For babies born with a certain heart defect, implantation of a "shunt" is essential to their survival. A new type of shunt can be expanded using light after it's been implanted, potentially ...

Patients who responded positively to shunt treatment experienced more beneficial changes in their heart's structure and function compared with nonresponders. After 2 years of follow-up, a post hoc ...

ATLANTA -- An interatrial shunt failed to provide a clinical benefit to people with heart failure (HF) overall in the RELIEVE-HF trial, though actual harm or benefit seemed to hinge on the patient's ...

Doctors say that identifying the right patients will be critical to the future of the field. Only time will tell, according ...

Inter-atrial shunts—investigational devices that create a small pathway for blood to pass from the left to the right side of the heart in order to improve heart failure symptoms and outcomes—may be ...

Study shows no benefit for heart failure overall but suggests different effects in those with preserved versus reduced ejection fraction Patients with heart failure who had a small shunt inserted ...

Patients with heart failure who had a small shunt inserted between the heart's left and right atria did not see any significant benefits overall compared with those who received a placebo procedure ...

Jimmy McMillan, 69, of West Columbia felt his health growing worse as his heart failure progressed. “I would have trouble just walking down to the mailbox and back without having to stop and catch my ...

SHREVEPORT, La. -- LSU Health Shreveport is one of only 25 sites around the country participating in a major clinical trial for individuals with stiff heart syndrome. About half of of patients with ...